The AcrAB efflux pump contributes to the virulence of Enteroaggregative E. coli by influencing the aggregative behavior
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1633585 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Martina Laudazzi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology and Biotechnologies "Charles Darwin", Institut Pasteur in Italy, Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Escherichia coli Proteins, Bacterial Adhesion, ATP-Binding Cassette, Sub-Family C Proteins, Escherichia coli. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Multidrug efflux pumps play a major role in the emergence of antibiotic resistance. AcrAB is particularly important among them, as it is the main RND pump in Escherichia coli and other Enterobacteriaceae . In addition to contributing to multidrug resistance, AcrAB also plays a significant role in the virulence of several pathogens. Here, we report that AcrAB contributes to both adhesion to host cells and biofilm formation in EAEC, an enteropathogenic group of E. coli known to cause both acute and persistent diarrhea. EAEC is an emerging pathotype of E. coli characterized by its ability to adhere extensively to epithelial cells in an aggregative manner and to form voluminous biofilms, which favor infection persistence. We found that the deletion of acrB prevents biofilm formation and reduces the export of extracellular DNA (eDNA). By using a specific inhibitor of AcrB, we confirmed the requirement of AcrB transporter activity for biofilm biogenesis. The characteristic aggregative pattern of EAEC is also strongly impaired in the absence of AcrB or in the presence of an efflux-defective AcrB D408A transporter, while it is restored in the Δ acrB strain complemented with acrB . Finally, we show that the EAEC 17-2 Δ acrB derivative is significantly less lethal than the wild type in Caenorhabditis elegans . Complementation with the acrB gene, but not with the acrB D408A allele, fully restores the virulence phenotype after infection. Overall, our results confirm the relevance of the AcrAB efflux pump as a virulence determinant and contribute to understanding the mechanisms adopted by EAEC to form thick biofilms and copious adherence to the epithelial cells, both features enhancing persistence during infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology and Biotechnologies "Charles Darwin", Institut Pasteur in Italy, Sapienza University of Rome, Rome, Italy.
- Microbiology and Virology, San Gallicano Dermatological Institute, IRCCS, Rome, Italy.
- Institute of Molecular Biology and Pathology (IBPM), CNR National Research Council, Rome, Italy.
Zitieren
APA
Laudazzi, M., Schifano, E., Sivori, F., Altieri, L., Uccelletti, D., Di Domenico, E. G., Colonna, B., Pasqua, M., & Prosseda, G. (2025). The AcrAB efflux pump contributes to the virulence of Enteroaggregative E. coli by influencing the aggregative behavior. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1633585
Vancouver
Laudazzi M, Schifano E, Sivori F, Altieri L, Uccelletti D, Di Domenico EG, et al. The AcrAB efflux pump contributes to the virulence of Enteroaggregative E. coli by influencing the aggregative behavior. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1633585
BibTeX
@article{Laudazzi2025,
author = {Laudazzi, Martina and Schifano, Emily and Sivori, Francesca and Altieri, Ludovica and Uccelletti, Daniela and Di Domenico, Enea G and Colonna, Bianca and Pasqua, Martina and Prosseda, Gianni},
title = {The AcrAB efflux pump contributes to the virulence of Enteroaggregative E. coli by influencing the aggregative behavior},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1633585}
}
EUVIMED